Constantine Keith L, Mueller Luciano, Metzler William J, McDonnell Patricia A, Todderud Gordon, Goldfarb Valentina, Fan Yi, Newitt John A, Kiefer Susan E, Gao Mian, Tortolani David, Vaccaro Wayne, Tokarski John
Bristol Myers Squibb Research and Development, Princeton, New Jersey 08543, USA.
J Med Chem. 2008 Oct 9;51(19):6225-9. doi: 10.1021/jm800747w. Epub 2008 Sep 5.
Fragment-like inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK2) include 5-hydroxyisoquinoline (IC50 approximately 85 microM). Modeling studies identified four possible binding modes for this compound. Two-dimensional (1)H-(1)H NOESY data obtained with selectively protonated samples of MK2 in complex with 5-hydroxyisoquinoline demonstrated that two of the four predicted binding modes are well populated. A second small isoquinoline was subsequently shown to bind in a single mode. NMR and modeling studies using this general approach are expected to facilitate "scaffold hopping" and structure-guided elaborations of fragment-like kinase inhibitor cores.
丝裂原活化蛋白激酶激活的蛋白激酶2(MK2)的类片段抑制剂包括5-羟基异喹啉(IC50约为85微摩尔)。建模研究确定了该化合物的四种可能结合模式。用MK2与5-羟基异喹啉复合物的选择性质子化样品获得的二维(1)H-(1)H NOESY数据表明,四种预测结合模式中的两种占有率很高。随后发现第二种小异喹啉以单一模式结合。预计使用这种通用方法进行的核磁共振(NMR)和建模研究将有助于“骨架跳跃”以及对类片段激酶抑制剂核心进行结构导向的修饰。